Cargando…
322. Risk Factors for COVID-19 Disease Severity Using Electronic-Health Records in a Real-World Cohort in the United States
BACKGROUND: Over 32 million cases of COVID-19 have been reported in the US. Outcomes range from mild upper respiratory infection to hospitalization, acute respiratory failure, and death. We assessed risk factors associated with severe disease, defined as hospitalization within 21 days of diagnosis o...
Autores principales: | Rizzo, Shemra, Gan, Ryan, Chawla, Devika, Zalocusky, Kelly, Chen, Xin, Chia, Yifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644129/ http://dx.doi.org/10.1093/ofid/ofab466.524 |
Ejemplares similares
-
515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
281. Prevalence of Influenza Co-infection in a Real-world Cohort of COVID-19 Patients in the U.S
por: Chawla, Devika, et al.
Publicado: (2021) -
26. Risk of Post–COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database
por: Jovanoski, Nick, et al.
Publicado: (2021) -
1518. Real-World Comparative Effectiveness of Baloxavir Marboxil versus Oseltamivir on Influenza-Related Complication and Resource Utilization
por: Neuberger, Eddie, et al.
Publicado: (2020)